Michael Schmertzler

Michael Schmertzler is currently Chairman at PTC Therapeutics, Inc. since 2004, Director at Dispel LLC, Managing Director and Co-Head at CSFB Private Equity Partners LLC, Director at The LOR Foundation, Inc., Director at AgNovos Healthcare LLC, Director at Berryville Holdings LLC since 2014, Director at SHY Therapeutics LLC since 2015, and Trustee at Phillips Academy Andover since 2021.
Former roles include Chief Executive Officer & Director at Kolltan Pharmaceuticals, Inc. in 2012, Director at Coltec Industries, Inc., Director at Idenix Pharmaceuticals LLC, Director at Cytokinetics, Inc. from 2003 to 2010, Director at Segway, Inc., Independent Director at Lehman Commercial Paper, Inc., Director at New York Academy of Sciences, Director at Manhattan Theatre Club, Inc., Managing Director & Chief Financial Officer at Lehman Brothers, Kuhn, Loeb, Inc., Managing Director at Aries Advisors LLC from 2001 to 2015, Director at Colt Industries, Inc., Director at National Outdoor Leadership School, Director at Cain Chemical, Inc., Director at Credit Suisse Americas Foundation, Director at The Addison Gallery of American Art, Head-International Sales & Trading at Lehman Brothers, Inc., Senior Manager-Institutional Private Equity at Credit Suisse First Boston Equity Partners LP from 1986 to 2001, Principal at Credit Suisse First Boston LLC in 2001, President at Morgan Stanley Leveraged Capital Fund, Inc., and Head-International Investment Banking at Shearson Lehman Brothers, Inc. Education includes an MBA from Harvard Business School and an undergraduate degree from Yale College conferred in 1998.